Showing 1 - 2 results of 2 for search 'Susan E. Shoaf', query time: 0.02s Refine Results
  1. 1
    Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters

    Regulatory guidelines do not accurately predict tolvaptan and metabolite interactions at BCRP, OATP1B1, and OAT3 transporters by Susan E. Shoaf, Patricia Bricmont, Jennifer Repella Gordon

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4

    Tolerability of Aquaretic-Related Symptoms Following Tolvaptan for Autosomal Dominant Polycystic Kidney Disease: Results From TEMPO 3:4 by Olivier Devuyst, Arlene B. Chapman, Susan E. Shoaf, Frank S. Czerwiec, Jaime D. Blais

    Published 2017-11-01
    Get full text
    Article

Search Tools: